Ceramic-on-ceramic THA Implants in Patients Younger Than 20 Years

Hannouche, Didier; Devriese, Flore; Delambre, Jérôme; Zadegan, Frédéric; Tourabaly, Idriss; Sedel, L.; Chevret, Sylvie; Nizard, Rémy

doi:10.1007/s11999-015-4546-9

Cited by 63 publications

(58 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results with modern Al-Al THAs in very young patients, who may want to perform strenuous activities and sports, have been promising. In a retrospective study, Hannouche et al 71 examined the results of 113 primary Al-Al THAs performed in 91 patients younger than 20 years at the time of surgery. The most common reason for THA was avascular necrosis of the femoral head in 56.2% of the cases.…”

Section: Long-term Results Of Ceramic Bearingsmentioning

confidence: 99%

Third-generation pure alumina and alumina matrix composites in total hip arthroplasty

et al. 2018

Self Cite

View full text Add to dashboard Cite

Wear, corrosion and periprosthetic osteolysis are important causes of failure in joint arthroplasty, especially in young patients.Ceramic bearings, developed 40 years ago, are an increasingly popular choice in hip arthroplasty. New manufacturing procedures have increased the strength and reliability of ceramic materials and reduced the risk of complications.In recent decades, ceramics made of pure alumina have continuously improved, resulting in a surgical-grade material that fulfills clinical requirements.Despite the track record of safety and long-term results, third-generation pure alumina ceramics are being replaced in clinical practice by alumina matrix composites, which are composed of alumina and zirconium.In this review, the characteristics of both materials are discussed, and the long-term results with third-generation alumina-on-alumina bearings and the associated complications are compared with those of other available ceramics.Cite this article: EFORT Open Rev 2018;3:7-14. DOI: 10.1302/2058-5241.3.170034

show abstract

Section: Long-term Results Of Ceramic Bearingsmentioning

confidence: 99%

Third-generation pure alumina and alumina matrix composites in total hip arthroplasty

et al. 2018

Self Cite

View full text Add to dashboard Cite

show abstract

“…Recently, Tibbo et al reported the 10-year survivorship free from any revision was 100% for highly crosslinked polyethylene liners and 66% for conventional polyethylene liners [ 8 ]. The Ceramic-on-ceramic bearing surface, characterized by its superior hardness and smoothness, has the lowest wear rates in comparison to all other bearing surfaces in THA [ 30 , 31 ]. In our study, only one patient underwent a revision arthroplasty due to aseptic loosening.…”

Section: Discussionmentioning

confidence: 99%

Pigmented villonodular synovitis does not influence the outcome following cementless total hip arthroplasty using ceramic-on-ceramic articulation: a case-control study with middle-term follow-up

Xu¹,

Bell

et al. 2018

J Orthop Surg Res

View full text Add to dashboard Cite

BackgroundPigmented villonodular synovitis (PVNS) is a relatively rare, locally aggressive, and potentially recurrent synovial disease of large joints. The purpose of this study was to investigate (1) the disease recurrence rate and (2) the treatment outcomes including Harris hip scores, complications, and revision following cementless total hip arthroplasty (THA) with ceramic-on-ceramic (CoC) articulation in patients with PVNS.MethodsTwenty-two patients (14 females and 8 males) with histologically confirmed PVNS underwent cementless THA using CoC bearings between 2000 and 2013. Three patients with less than 5-year follow-up were excluded. The mean age was 35.2 years (range, 22–58 years) with a mean follow-up of 8.6 years (range, 6.9–10.8 years). A control group was matched in a 2:1 ratio with the PVNS group for age, sex, body mass index (BMI), year of surgery, and American Society of Anesthesiologists score (ASA). Postoperative outcome variables included disease recurrence, Harris Hip Scores (HHS) at the latest follow-up, complications (dislocation, squeaking, ceramic fracture), and any-cause revision. A Kaplan-Meier implant survivorship curve with 95% confidence interval (CI) of the two groups was generated.ResultsNo recurrence of PVNS was noted in the follow-up period. The HSS in the PVNS group was 92.6 ± 5.5, which was similar to the control group (93.4 ± 4.6, p = 0.584) at the last follow-up visit. No patients sustained dislocation, osteolysis, or any ceramic fracture within the study duration. One patient in the PVNS group had a complication of squeaking, but did not require revision. Another patient in the PVNS group underwent revision surgery due to aseptic loosening. There was no significant difference in revision rates between the two groups (p = 1.000). The implant survivorship free of any revision was 90.0% (95% CI, 73.2% to 100%) in the PVNS group and 92.5% (95% CI, 82.6% to 100%) in the control group at 10 years (p = 0.99).ConclusionsFor young and active patients with end-stage PVNS of the hips, cementless THA using CoC bearing has similar functional outcome scores, a low complication rate, and similar implant survivorship compared to the control group.

show abstract

“…98,99 With ceramic-on-ceramic bearings in patients younger than 20 years, short-to mid-term results have been promising, 100 with a survival rate of 90.3% after 10 years. 101 In a study of 88 patients who had THA, 25 years or younger, at 2 years follow-up by Clohisy et al, hip function assessed by Harris hip score improved, and in patients with alternative bearing surfaces and highly crosslinked polyethylene, there were no revisions for osteolysis or polyethylene wear. 98 A similar study at a mean 6.6 years follow-up in 35 THAs, performed in patients younger than age 20, found significant improvement in function and only one revision secondary to polyethylene wear.…”

Section: Hip Replacement and Resurfacingmentioning

confidence: 99%

Treatment of Early-Onset Hip Osteoarthritis in Young Patients

et al. 2018

View full text Add to dashboard Cite

Pain and debilitating symptoms due to hip osteoarthritis (OA) can significantly compromise quality of life in young, active patients. The management of the young adult with hip OA presents a unique set of challenges, with symptoms that originate from a variety of underlying hip pathologies, and patient age spanning from youth through middle age. Early options for hip OA include nonoperative treatment with anti-inflammatory medications, physical therapy, and injections. For patients with structural hip abnormalities (femoroacetabular impingement or dysplasia), arthroscopy or reconstructive osteotomy are acceptable treatment options. In advanced disease, joint-preserving techniques are often ineffective, and patients may require joint resurfacing or replacement. The treatment strategies for early hip OA continues to evolve with the development of new and refined surgical techniques, especially in the setting of underlying hip pathology, and a growing popularity of utilizing biologic agents. The purpose of this manuscript is to review current conservative and surgical management and to describe an algorithm for treatment of early-onset hip OA.

show abstract

Ceramic-on-ceramic THA Implants in Patients Younger Than 20 Years

Cited by 63 publications

References 47 publications

Third-generation pure alumina and alumina matrix composites in total hip arthroplasty

Third-generation pure alumina and alumina matrix composites in total hip arthroplasty

Pigmented villonodular synovitis does not influence the outcome following cementless total hip arthroplasty using ceramic-on-ceramic articulation: a case-control study with middle-term follow-up

Treatment of Early-Onset Hip Osteoarthritis in Young Patients

Contact Info

Product

Resources

About